EBAG9 and neoplasm: Similarly, in patients with ovarian cancer who did not respond to therapy, a significantly higher expression of RCAS1 within both the cancer cells and microenvironmental TAMs (tumor-associated macrophages) or CAFs (cancer associated fibroblasts) was observed in comparison to patients who responded to the treatment [12].